Article
Overactive bladder patients respond favorably to botulinum injectionsin small studies
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Pivotal data for lumasiran in PH1 published in NEJM
Nedosiran explored in primary hyperoxaluria type 3
Enrollment completed in pivotal trial of nedosiran for hyperoxaluria
FDA approves androgen inhibitor for metastatic PCa
Blood test could guide treatment for kidney cancer
BCG for bladder cancer in short supply
UK’s MHRA approves nogapendekin alfa inbakicept plus BCG in NMIBC
Enrollment complete for phase 3 UTOPIA trial in LG-IR-NMIBC
Zelenectide pevedotin plus pembrolizumab shows promising anti-tumor activity in mUC
FDA and EMA authorize phase 3 trial of masitinib for mCRPC